CHICAGO — In this Healio Video Perspective from the AAO meeting, Sheri Rowen, MD, of NVISION Eye Centers, discusses the link between dry eye disease and menopause.“Menopause can contribute to women losing the ability to make their own natural tears,” s…
Author: Healio ophthalmology
Cyclodialysis procedure with scleral reinforcement lowers IOP in open-angle glaucoma
A bio-interventional cyclodialysis procedure with allograft scleral reinforcement helped lower IOP in patients with glaucoma through uveoscleral outflow enhancement, according to a study.In the study published in Clinical Ophthalmology, Robert N. Weinr…
Glaucoma: Top items in ophthalmology for 2024
The top glaucoma articles on Healio in 2024 included an overview of a more holistic approach to managing the disease as well as safety and efficacy data for a sustained-release bimatoprost drug delivery platform.Check out these stories and more below.‘…
VIDEO: OCS-01 eye drop shows efficacy, safety for treatment of DME
CHICAGO — In this Healio Video Perspective from the AAO meeting, Arshad M. Khanani, MD, MA, FASRS, shares promising data from an ongoing phase 2/3 study investigating OCS-01, an eye drop for the treatment of diabetic macular edema.“In stage one, we saw…
VIDEO: ImprimisRx highlights new offerings for ocular surgery
CHICAGO — In this Healio Video Perspective from the AAO meeting, John Saharek, CEO and president of ImprimisRx, previews two recently launched ophthalmic surgery products.According to Saharek, Repackaged Vigamox (moxifloxacin 5 mg/mL) is an injectable …
FDA news: Top items in ophthalmology for 2024
Healio’s top FDA articles in ophthalmology this year included updates on the Vabsymo prefilled syringe, two new aflibercept biosimilars and an oral therapy for Stargardt disease.Check out 2024’s top FDA news below.FDA clears Faros anterior cataract sur…
VIDEO: Latanoprost implant for glaucoma shows improved IOP at 48 weeks
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Michael Coote, MB, BS, FRANZCO, GAICD, of Melbourne Eye Specialists, presents positive safety and efficacy data for PA5108, an ocular implant for the treatment of glaucoma.The phase 2 cl…
Alcon recalls one lot of Systane single-use eye drops due to fungal contamination
Alcon Laboratories announced the voluntary recall of one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, following a consumer complaint that led to the discovery of fungal contamination in the drops.“Investigation of this event is …
Q&A: Cure Blindness Project expands reach to prevent blindness
Nearly 30 years after the organization’s founding, Cure Blindness Project, previously known as Himalayan Cataract Project and HCP Cureblindness, continues to fight preventable blindness in underserved parts of the world.The organization underwent a nam…
Top blogs in ophthalmology for 2024
Healio’s top ophthalmology blogs from 2024 covered topics including dry eye and photophobia, the latest in IOL technology and the use of AI for marketing.Check out this year’s top blog items below.BLOG: The FTC’s noncompete ban: What physicians need to…
Galimedix begins study of GAL-101 eye drops for dry AMD
Galimedix Therapeutics announced the initiation of its phase 2 eDREAM study to assess the safety and efficacy of GAL-101 eye drops in patients with dry age-related macular degeneration, according to a company press release.“GAL-101 eye drops have alrea…
VIDEO: New therapies may ‘move the needle’ on treatment of diabetic retinopathy
CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Michael S. Ip, MD, discusses the available treatments for nonproliferative diabetic retinopathy.Ip said about 50% of responders to an American Society of Retina…
Safety monitoring board approves continuation of gene therapy trial for GA
The data and safety monitoring board for a phase 1/2 study clinical trial of a geographic atrophy gene therapy approved continuation of the second phase of the study due to positive safety results, according to a press release from Ocugen.The ArMaDa st…
Refractive surgery: Top items in ophthalmology for 2024
The top refractive surgery articles on Healio this year included updates on the EVO ICL, EyeOL UK presbyopic phakic lens and laser-induced refractive index change.Check out 2024’s top refractive surgery items below.Evolutionary mindset needed for refra…
Glaukos submits new drug application for corneal cross-linking therapy
Glaukos submitted a new drug application to the FDA for Epioxa, an epithelium-on corneal cross-linking iLink therapy for the treatment of keratoconus, according to a company press release.Epioxa is designed to enhance cross-linking by preserving the co…
FDA, Opus Genetics reach special protocol assessment agreement for APX3330 trial
Opus Genetics and the FDA have reached an agreement on a special protocol assessment for a phase 3 clinical trial investigating oral APX3330 for the treatment of moderate to severe nonproliferative diabetic retinopathy.According to a company press rele…
FDA clears investigational new drug application for Stargardt disease gene therapy
The FDA cleared the investigational new drug application for a phase 1/2 study investigating VG801, a treatment for Stargardt disease and other retinal diseases associated with mutations in the ABCA4 gene.According to a press release from ViGeneron Gmb…
VIDEO: Artevo 850 offers improved comfort for surgeons, patients
CHICAGO — In this Healio Video Perspective from the AAO meeting, I. Paul Singh, MD, discusses his experience with the Artevo 850 heads-up display and its positive impact on ergonomics during surgery.Singh overviewed some of the features of the Artevo 8…
VIDEO: Duravyu for wet AMD shows positive 12-month outcomes vs. aflibercept
CHICAGO — In this Healio Video Perspective from the AAO meeting, Ramiro Ribeiro, MD, PhD, of EyePoint Pharmaceuticals, shares phase 2 data investigating Duravyu for wet age-related macular degeneration treatment vs. aflibercept.According to Ribeiro, Du…
‘Critical for the future of our country’: FDA updates definition of ‘healthy’ foods
The FDA has updated the definition of “healthy,” so food labels will have to abide by new rules to earn the title, according to a press release.In the United States, there is a worsening crisis of diet-related, preventable chronic diseases, and this “r…